Two Sigma Securities’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Two Sigma Securities’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,521	Closed	-$43.1K	–	3643
2023 Q2	$43.1K	Buy	+19,521	New	+$40.5K	﹤0.01%	2415
2023 Q1	–	Sell	-12,575	Closed	-$23.5K	–	3465
2022 Q4	$23.5K	Buy	+12,575	New	+$31.4K	﹤0.01%	2256

Two Sigma Securities's PRTK Position: Q3 2023 in Review

Two Sigma Securities sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 19,521 shares — an estimated $43.1K sold.

Two Sigma Securities first reported a position in PRTK in Q4 2022 and held it in 2 quarters. The position peaked at $43.1K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Two Sigma Securities reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Two Sigma Securities sold 19,521 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $43.1K.
Two Sigma Securities first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2022 and held it in 2 quarters.
Two Sigma Securities's Paratek Pharmaceuticals, Inc. position peaked at $43.1K in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.